Shengnan Liu

5.3k total citations · 1 hit paper
180 papers, 3.9k citations indexed

About

Shengnan Liu is a scholar working on Molecular Biology, Cancer Research and Plant Science. According to data from OpenAlex, Shengnan Liu has authored 180 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 25 papers in Cancer Research and 18 papers in Plant Science. Recurrent topics in Shengnan Liu's work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (9 papers). Shengnan Liu is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (9 papers). Shengnan Liu collaborates with scholars based in China, United States and United Kingdom. Shengnan Liu's co-authors include Jingbo Pi, Qiang Zhang, Qisen Xiang, Yunfang Ma, Yanhong Bai, Xinrong Zhang, Chengxiao Zhang, Hongni Wang, Lihua Shen and Sichun Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Shengnan Liu

173 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway

2022 264 citations Shengnan Liu, Jingbo Pi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shengnan Liu China	31	1.5k	506	482	431	413	180	3.9k
Jianyong Li China	37	2.0k 1.3×	434 0.9×	446 0.9×	496 1.2×	267 0.6×	197	4.4k
Xiaomeng Li China	33	2.0k 1.3×	611 1.2×	476 1.0×	606 1.4×	306 0.7×	255	4.8k
Yanxin Li China	35	2.1k 1.4×	501 1.0×	332 0.7×	278 0.6×	244 0.6×	172	3.8k
Jiali Liu China	38	2.5k 1.6×	663 1.3×	340 0.7×	613 1.4×	448 1.1×	267	5.7k
Min Jia China	36	1.8k 1.2×	334 0.7×	345 0.7×	193 0.4×	450 1.1×	137	4.3k
Dong Hee Kim South Korea	37	2.2k 1.5×	297 0.6×	505 1.0×	458 1.1×	220 0.5×	286	5.3k
Yanli Liu China	40	3.2k 2.1×	509 1.0×	718 1.5×	687 1.6×	674 1.6×	328	6.4k
Li Sui China	37	1.4k 0.9×	323 0.6×	368 0.8×	368 0.9×	174 0.4×	186	4.0k
Jing Wen China	44	1.7k 1.1×	348 0.7×	212 0.4×	667 1.5×	725 1.8×	184	5.2k
Branislav Ruttkay-Nedecký Czechia	28	1.4k 0.9×	222 0.4×	477 1.0×	763 1.8×	555 1.3×	80	4.6k

Countries citing papers authored by Shengnan Liu

Since Specialization

Citations

This map shows the geographic impact of Shengnan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Liu more than expected).

Fields of papers citing papers by Shengnan Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengnan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Liu. The network helps show where Shengnan Liu may publish in the future.

Co-authorship network of co-authors of Shengnan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Liu. A scholar is included among the top collaborators of Shengnan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Liu. Shengnan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Ziwei, Shengnan Liu, Yachao Wang, et al.. (2025). Sonodynamic and Bioorthogonal Sonocatalytic Thrombotic Therapy Based on AIE Cationic Tetranuclear Ir(III) Complex Nanoplatform Guided by NIR‐Chemiluminescence Imaging. Advanced Materials. 37(39). e2503599–e2503599. 9 indexed citations

Liu, Shengnan, Jingbo Pi, & Qiang Zhang. (2025). Origins of Ultrasensitivity and Complex Signaling Dynamics of Cellular Hydrogen Peroxide and Peroxiredoxin. Antioxidants. 14(2). 235–235. 1 indexed citations

Wei, Ning, Yao Zhang, Shengnan Liu, et al.. (2025). Hydro-mechanical interactions in CO2 storage: Critical parameters influencing coal mine at Shenhua's CCS site. Engineering Geology. 352. 108087–108087. 3 indexed citations

Liu, Shengnan, Yuanyuan Liu, Xiaohan Wu, et al.. (2025). Efficacy and prognostic factors of anti-VEGF treatment for neovascular age-related macular degeneration: An OCTA imaging-based deep learning analysis. Photodiagnosis and Photodynamic Therapy. 55. 104701–104701. 2 indexed citations

Liu, Shengnan, Shengnan Liu, Heyu Wang, et al.. (2024). Fermented Ginsenosides Alleviate Acute Liver Injury Induced by CCl ₄ in Mice by Regulating the AKT/mTOR Signaling Pathway. Journal of Medicinal Food. 27(10). 961–970. 4 indexed citations

Liu, Shengnan, Hao Wang, Hao Wang, et al.. (2024). Loss of Bcl‐3 regulates macrophage polarization by promoting macrophage glycolysis. Immunology and Cell Biology. 102(7). 605–617. 2 indexed citations

Xu, Jun, Weijie Song, Yang Liu, et al.. (2024). Discovery of the Next-Generation Platinum-Based Anticancer Agents for Combating Oxaliplatin-Induced Drug Resistance. Journal of Medicinal Chemistry. 67(12). 10190–10210. 3 indexed citations

Liu, Shengnan, et al.. (2024). Metabolizable alloy clusters assemble nanoinhibitor for enhanced radiotherapy of tumor by hypoxia alleviation and intracellular PD-L1 restraint. Journal of Nanobiotechnology. 22(1). 774–774. 2 indexed citations

Yang, Jing, Shengnan Liu, P. A. Karalkin, et al.. (2024). Bioengineering autologous cartilage grafts for functional posterior lamellar eyelid reconstruction: A preliminary study in rabbits. Acta Biomaterialia. 179. 106–120. 2 indexed citations

10.

Liu, Shengnan & Hongbiao Yin. (2023). Opening the black box: How professional learning communities, collective teacher efficacy, and cognitive activation affect students’ mathematics achievement in schools. Teaching and Teacher Education. 139. 104443–104443. 7 indexed citations

11.

Liu, Shengnan, Chao Zhang, & Jing Wan. (2023). The correlation between T-wave abnormalities and adverse cardiovascular events and echocardiographic changes in hypertensive patients. Clinical and Experimental Hypertension. 45(1). 2185252–2185252. 3 indexed citations

12.

Liu, Shengnan, et al.. (2022). Monoglycocalix[4]arene-based nanoparticles for tumor selective drug delivery via GLUT1 recognition of hyperglycolytic cancers. Organic & Biomolecular Chemistry. 20(24). 4884–4887. 5 indexed citations

13.

Wang, Yucheng, Xiaohan Yao, Mei Ma, et al.. (2021). miR-130b inhibits proliferation and promotes differentiation in myocytes via targeting Sp1. Journal of Molecular Cell Biology. 13(6). 422–432. 9 indexed citations

14.

Zhang, Shunjie, Xinyu Wang, Ru Zhang, et al.. (2021). A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers. Analytica Chimica Acta. 1167. 338593–338593. 11 indexed citations

15.

Wang, Hui, Mei Ma, Yuying Li, et al.. (2021). miR‐183 and miR‐96 orchestrate both glucose and fat utilization in skeletal muscle. EMBO Reports. 22(9). e52247–e52247. 8 indexed citations

16.

Ren, Peng, Xiaole Ma, Min Zhang, et al.. (2019). Comparison of the Use of Blink Rate and Blink Rate Variability for Mental State Recognition. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 27(5). 867–875. 17 indexed citations

17.

Liu, Shengnan, et al.. (2018). Discovery of Nonpeptide, Reversible HER1/HER2 Dual-Targeting Small-Molecule Inhibitors as Near-Infrared Fluorescent Probes for Efficient Tumor Detection, Diagnostic Imaging, and Drug Screening. Analytical Chemistry. 91(2). 1507–1515. 27 indexed citations

18.

Dong, Zhiming, Aili Zhang, Shengnan Liu, et al.. (2017). Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer. Molecular Cancer Research. 15(7). 800–810. 101 indexed citations

19.

Guo, Wei, Zhiming Dong, Shengnan Liu, et al.. (2017). Promoter hypermethylation‐mediated downregulation of miR‐770 and its host gene MEG3, a long non‐coding RNA, in the development of gastric cardia adenocarcinoma. Molecular Carcinogenesis. 56(8). 1924–1934. 50 indexed citations

20.

Liu, Shengnan, Wei Tian, Jing Wang, et al.. (2014). Two Single-Nucleotide Polymorphisms in the DKK1 Gene Are Associated with Developmental Dysplasia of the Hip in the Chinese Han Female Population. Genetic Testing and Molecular Biomarkers. 18(8). 557–561. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact